Yi Gu

4.6k total citations
92 papers, 3.2k citations indexed

About

Yi Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi Gu has authored 92 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Yi Gu's work include Protein Kinase Regulation and GTPase Signaling (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Pharmacological Effects of Natural Compounds (8 papers). Yi Gu is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Pharmacological Effects of Natural Compounds (8 papers). Yi Gu collaborates with scholars based in China, United States and Australia. Yi Gu's co-authors include David A. Williams, Jamie E. Siefring, Yi Zheng, Aparna Jasti, Chad E. Harris, José A. Cancelas, Simon J. Atkinson, Marie–Dominique Filippi, Jianguo Sun and Michael Jansen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yi Gu

86 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Gu China 28 1.7k 702 650 605 595 92 3.2k
Katsuhiko Enomoto Japan 33 2.0k 1.2× 553 0.8× 499 0.8× 280 0.5× 197 0.3× 103 3.8k
Andra R. Frost United States 44 3.3k 1.9× 1.8k 2.5× 1.1k 1.7× 400 0.7× 622 1.0× 120 5.7k
Lidija Klampfer United States 28 1.6k 0.9× 1.2k 1.7× 486 0.7× 683 1.1× 277 0.5× 48 3.2k
Phyllis A. Svingen United States 32 2.6k 1.5× 1.2k 1.8× 431 0.7× 612 1.0× 194 0.3× 57 4.0k
Burkhard Jansen Austria 42 3.6k 2.1× 1.8k 2.5× 551 0.8× 985 1.6× 364 0.6× 99 5.4k
Evette S. Radisky United States 35 2.1k 1.3× 1.4k 2.0× 1.2k 1.8× 332 0.5× 247 0.4× 86 3.8k
Germán Pihán United States 26 2.3k 1.4× 1.0k 1.4× 500 0.8× 300 0.5× 389 0.7× 76 4.1k
Min H. Kang United States 38 3.6k 2.1× 1.7k 2.5× 689 1.1× 400 0.7× 640 1.1× 140 5.2k
Jianxin Gu China 37 3.2k 1.9× 965 1.4× 740 1.1× 1.2k 2.1× 348 0.6× 200 4.8k
Bing Tian United States 36 2.1k 1.2× 615 0.9× 741 1.1× 1.1k 1.9× 413 0.7× 74 3.9k

Countries citing papers authored by Yi Gu

Since Specialization
Citations

This map shows the geographic impact of Yi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Gu more than expected).

Fields of papers citing papers by Yi Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Gu. The network helps show where Yi Gu may publish in the future.

Co-authorship network of co-authors of Yi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Gu. A scholar is included among the top collaborators of Yi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Gu. Yi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Wei, et al.. (2025). Modulation of Intestinal Barrier Function and Wnt/β- Catenin Pathway by Sanzi Formula in Colorectal Adenoma Development. The Turkish Journal of Gastroenterology. 36(9). 547–555.
2.
3.
4.
Zhang, Bowei, et al.. (2023). Long Non-Coding RNA LPP-AS2 Plays an Anti-Tumor Role in Thyroid Carcinoma by Regulating the miR-132-3p/OLFM1 Axis. Critical Reviews in Eukaryotic Gene Expression. 33(5). 73–86.
5.
Hu, Jiangang, Yi Gu, Jiakun Zuo, et al.. (2022). Identification of novel biofilm genes in avian pathogenic Escherichia coli by Tn5 transposon mutant library. World Journal of Microbiology and Biotechnology. 38(8). 130–130. 9 indexed citations
6.
Gu, Yi, Ying Shao, Dandan Fu, et al.. (2022). Acetoacetyl-CoA transferase ydiF regulates the biofilm formation of avian pathogenic Escherichia coli. Research in Veterinary Science. 153. 144–152. 1 indexed citations
7.
Zhao, Jing, Xin Ye, Yan Xu, et al.. (2016). EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases. Cancer Chemotherapy and Pharmacology. 78(6). 1305–1310. 44 indexed citations
8.
Zhu, Guanshan, Xin Ye, Zhengwei Dong, et al.. (2015). Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell Lung Cancer. Journal of Molecular Diagnostics. 17(3). 265–272. 161 indexed citations
9.
Yin, Xiaolu, Tianwei Zhang, Xinying Su, et al.. (2015). Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients. PLoS ONE. 10(12). e0143468–e0143468. 16 indexed citations
10.
Liu, Yao-Bin, Danhong Shen, Paul R. Gavine, et al.. (2014). HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma. British Journal of Cancer. 110(5). 1169–1178. 91 indexed citations
11.
Holt, Sarah V., Armelle Logié, Barry R. Davies, et al.. (2012). Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055). Cancer Research. 72(7). 1804–1813. 70 indexed citations
12.
Wang, Jiarui, Xiaojun Zhou, Jing Zhu, et al.. (2011). GO-function: deriving biologically relevant functions from statistically significant functions. Briefings in Bioinformatics. 13(2). 216–227. 65 indexed citations
13.
Gu, Yi, Guangji Wang, Jianguo Sun, et al.. (2009). Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Food and Chemical Toxicology. 47(9). 2257–2268. 111 indexed citations
14.
Sánchez‐Aguilera, Abel, Lena Müller, David Lucas, et al.. (2009). Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia. 24(1). 97–104. 42 indexed citations
15.
Gu, Yi, Guangji Wang, Jianguo Sun, & Xiaoyan Zhang. (2008). A new method for plasma citrate determination by reversed-phasehigh-performance liquid chromatography after ultrafiltrationextraction: An example for bioequivalence evaluation of a medicinalendogenous substance. Methods and Findings in Experimental and Clinical Pharmacology. 30(7). 513–513. 3 indexed citations
16.
Sun, Jianguo, Guangji Wang, Wei Wang, et al.. (2005). Simultaneous determination of loratadine and pseudoephedrine sulfate in human plasma by liquid chromatography–electrospray mass spectrometry for pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 39(1-2). 217–224. 19 indexed citations
17.
Gu, Yi. (2004). Determination of Residual Organic Solvents in Andrographolide Microcapsules by GC. Chinese Journal of Pharmaceuticals. 2 indexed citations
18.
Gu, Yi. (2004). Drug-resistant Mechanisms and Prevalence of Enterobacter cloacae Resistant to Multi-antibiotics. 4 indexed citations
19.
Filippi, Marie–Dominique, Chad E. Harris, Jarek Meller, et al.. (2004). Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils. Nature Immunology. 5(7). 744–751. 113 indexed citations
20.
Gu, Yi, Michael C. Byrne, Bruce J. Aronow, et al.. (2002). Rac2, a Hematopoiesis-Specific Rho GTPase, Specifically Regulates Mast Cell Protease Gene Expression in Bone Marrow-Derived Mast Cells. Molecular and Cellular Biology. 22(21). 7645–7657. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiko Enomoto Breakdown of academic impact, for papers by Andra R. Frost Breakdown of academic impact, for papers by Lidija Klampfer Breakdown of academic impact, for papers by Phyllis A. Svingen Breakdown of academic impact, for papers by Burkhard Jansen Breakdown of academic impact, for papers by Evette S. Radisky Breakdown of academic impact, for papers by Germán Pihán Breakdown of academic impact, for papers by Min H. Kang Breakdown of academic impact, for papers by Jianxin Gu Breakdown of academic impact, for papers by Bing Tian
Rankless by CCL
2026